INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (EIN 753269205) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

MARY EIKEN

Phone

5028914575

Tax Period

2023-01-01 to 2023-12-31

INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, founded in 2009, is a community nonprofit in the Diseases & Disorders sector that reported $2.3M in total revenue in fiscal year 2023. Revenue surged 39% from the prior year, signaling strong growth momentum. Expenses of $2.0M left a modest 10% surplus.

Mission

MEMBER ORGANIZATION DEDICATED TO ADVANCE OF EDUCATION OF GYNECOLOGIC CANCER

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,222,198

Program Service Revenue $864,632

Investment Income $177,083

Other Revenue $0

TOTAL REVENUE $2,263,913

Expense Breakdown

Grants Paid $0

Salaries & Benefits $599,723

Fundraising Expenses $0

Program Expenses $1,565,460

Other Expenses $1,437,407

TOTAL EXPENSES $2,037,130

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,263,913	$1,626,873	+0.4%
Expenses	$2,037,130	$1,642,597	+0.2%
Net Income	$226,783	$-15,724	-15.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

250

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$381,392

Total Directors

$381,392

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR KEIICHI FUJIWARA	PRESIDENT	1.00	Officer Director	$0	$0	$0
DR GRETA DREYER	PRESIDENT ELECT	1.00	Officer Director	$0	$0	$0
DR ANUJA JHINGRAN	VICE-PRESIDENT	1.00	Officer Director	$0	$0	$0
DR RAINER KIMMIG	SECRETARY TREASURER	1.00	Officer Director	$0	$0	$0
DR RITU SALANI	SECRETARY TREASURER ELECT	1.00	Officer Director	$0	$0	$0
DR ROBERT COLEMAN	PAST PRESIDENT	1.00	Director	$0	$0	$0
DR DAVID ATALLAH	BOARD MEMBER	1.00	Director	$0	$0	$0
DR RHONDA FARRELL	BOARD MEMBER	1.00	Director	$0	$0	$0
DR DILYARA KAIDAROVA	BOARD MEMBER	1.00	Director	$0	$0	$0
DR MARIO LEITAO JR	BOARD MEMBER	1.00	Director	$0	$0	$0
DR FERNANDO MALUF	BOARD MEMBER	1.00	Director	$0	$0	$0
DR XAVIER MATIA-GUIU	BOARD MEMBER	1.00	Director	$0	$0	$0
DR ALEXANDRA TAYLOR	BOARD MEMBER	1.00	Director	$0	$0	$0
DR AUDREY TSUNODA	BOARD MEMBER	1.00	Director	$0	$0	$0
DR HELEEN VAN BEEKHUIZEN	BOARD MEMBER	1.00	Director	$0	$0	$0
MARY EIKEN	CEO	40.00	Officer Director	$381,392	$0	$381,392
DR JOSEPH NG	BOARD MEMBER	1.00	Director	$0	$0	$0
DR PAUL COHEN	BOARD MEMBER	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,263,913	$2,037,130	$2,604,890	$226,783
2022	$1,626,873	$1,642,597	$2,255,423	$-15,724
2021	$1,297,279	$1,499,222	$2,240,690	$-201,943
2020	$1,459,696	$1,161,971	$2,493,547	$297,725
2019	$1,197,069	$1,412,076	$2,221,488	$-215,007
2018	$1,343,691	$1,503,762	$2,310,565	$-160,071

INTERNATIONAL GYNECOLOGIC CANCER SOCIETY